Renal Cell Carcinoma. The purpose of this study is to determine whether there is an overall
survival (OS) benefit between subjects treated with AGS-003 in combination with standard
treatment versus subjects treated with standard treatment alone.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.